Mode of Action, In Vitro Activity, and In Vivo Efficacy of AFN-1252, a Selective Antistaphylococcal FabI Inhibitor

The mechanism of action of AFN-1252, a selective inhibitor of Staphylococcus aureus enoyl-acyl carrier protein reductase (FabI), which is involved in fatty acid biosynthesis, was confirmed by using biochemistry, macromolecular synthesis, genetics, and cocrystallization of an AFN-1252–FabI complex. A...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Kaplan, Nachum, Albert, Monique, Awrey, Donald, Bardouniotis, Elias, Berman, Judd, Clarke, Teresa, Dorsey, Mandy, Hafkin, Barry, Ramnauth, Jaillal, Romanov, Vladimir, Schmid, Molly B., Thalakada, Rosanne, Yethon, Jeremy, Pauls, Henry W.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: American Society for Microbiology 2012
Gaiak:
Mechanisms of Action: Physiological Effects
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3486558/
https://ncbi.nlm.nih.gov/pubmed/22948878
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.01411-12
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak